200 related articles for article (PubMed ID: 24282568)
21. Prognostic significance of tumor-associated macrophages in ovarian cancer: A meta-analysis.
Yuan X; Zhang J; Li D; Mao Y; Mo F; Du W; Ma X
Gynecol Oncol; 2017 Oct; 147(1):181-187. PubMed ID: 28698008
[TBL] [Abstract][Full Text] [Related]
22. The Prognostic and Predictive Value of Dihydropyrimidine Dehydrogenase-Related Indicators in Clinical Outcomes of Chemotherapy in Colorectal Cancer Patients: a Systematic Review and Meta-Analysis.
Sun X; Guo S
Pathol Oncol Res; 2020 Jan; 26(1):121-131. PubMed ID: 30519982
[TBL] [Abstract][Full Text] [Related]
23. Prognostic and Clinicopathological Value of Rac1 in Cancer Survival: Evidence from a Meta-Analysis.
Lou S; Wang P; Yang J; Ma J; Liu C; Zhou M
J Cancer; 2018; 9(14):2571-2579. PubMed ID: 30026856
[No Abstract] [Full Text] [Related]
24. Aldehyde dehydrogenase 3A1 is robustly upregulated in gastric cancer stem-like cells and associated with tumorigenesis.
Wu D; Mou YP; Chen K; Cai JQ; Zhou YC; Pan Y; Xu XW; Zhou W; Gao JQ; Chen DW; Zhang RC
Int J Oncol; 2016 Aug; 49(2):611-22. PubMed ID: 27279633
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathological and Prognostic Significance of Cancer Stem Cell Markers in Ovarian Cancer Patients: Evidence from 52 Studies.
Tao Y; Li H; Huang R; Mo D; Zeng T; Fang M; Li M
Cell Physiol Biochem; 2018; 46(4):1716-1726. PubMed ID: 29730663
[TBL] [Abstract][Full Text] [Related]
26. Prognostic and clinicopathological significance of glypican-3 overexpression in hepatocellular carcinoma: a meta-analysis.
Li J; Gao JZ; Du JL; Wei LX
World J Gastroenterol; 2014 May; 20(20):6336-44. PubMed ID: 24876756
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathological and prognostic value of hypoxia-inducible factor-1α in breast cancer: a meta-analysis including 5177 patients.
Zhao Z; Mu H; Li Y; Liu Y; Zou J; Zhu Y
Clin Transl Oncol; 2020 Oct; 22(10):1892-1906. PubMed ID: 32166713
[TBL] [Abstract][Full Text] [Related]
28. Prognostic Value of β-catenin Expression in Breast Cancer Patients: a Meta-analysis.
Zhang DP; Li XW; Lang JH
Asian Pac J Cancer Prev; 2015; 16(14):5625-33. PubMed ID: 26320427
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of progesterone receptor expression in ovarian cancer: a meta-analysis.
Luo H; Li S; Zhao M; Sheng B; Zhu H; Zhu X
Oncotarget; 2017 May; 8(22):36845-36856. PubMed ID: 28415663
[TBL] [Abstract][Full Text] [Related]
30. Prognostic Significance of High VEGF-C Expression for Patients with Breast Cancer: An Update Meta Analysis.
Zhang Z; Luo G; Tang H; Cheng C; Wang P
PLoS One; 2016; 11(11):e0165725. PubMed ID: 27812168
[TBL] [Abstract][Full Text] [Related]
31. Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling.
Sullivan JP; Spinola M; Dodge M; Raso MG; Behrens C; Gao B; Schuster K; Shao C; Larsen JE; Sullivan LA; Honorio S; Xie Y; Scaglioni PP; DiMaio JM; Gazdar AF; Shay JW; Wistuba II; Minna JD
Cancer Res; 2010 Dec; 70(23):9937-48. PubMed ID: 21118965
[TBL] [Abstract][Full Text] [Related]
32. Prognostic role of Twist or Snail in various carcinomas: a systematic review and meta-analysis.
Zhang P; Hu P; Shen H; Yu J; Liu Q; Du J
Eur J Clin Invest; 2014 Nov; 44(11):1072-94. PubMed ID: 25257753
[TBL] [Abstract][Full Text] [Related]
33. Metformin targets ovarian cancer stem cells in vitro and in vivo.
Shank JJ; Yang K; Ghannam J; Cabrera L; Johnston CJ; Reynolds RK; Buckanovich RJ
Gynecol Oncol; 2012 Nov; 127(2):390-7. PubMed ID: 22864111
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of programmed cell death ligand-1 expression in ovarian cancer: an updated meta-analysis.
Piao J; Lim HJ; Lee M
Obstet Gynecol Sci; 2020 May; 63(3):346-356. PubMed ID: 32489980
[TBL] [Abstract][Full Text] [Related]
35. Prognostic roles of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in ovarian cancer: a meta-analysis of retrospective studies.
Zhao Z; Zhao X; Lu J; Xue J; Liu P; Mao H
Arch Gynecol Obstet; 2018 Apr; 297(4):849-857. PubMed ID: 29368160
[TBL] [Abstract][Full Text] [Related]
36. The molecular signature of AML with increased ALDH activity suggests a stem cell origin.
Blume R; Rempel E; Manta L; Saeed BR; Wang W; Raffel S; Ermakova O; Eckstein V; Benes V; Trumpp A; Ho AD; Lutz C
Leuk Lymphoma; 2018 Sep; 59(9):2201-2210. PubMed ID: 29334844
[TBL] [Abstract][Full Text] [Related]
37. Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer.
Charafe-Jauffret E; Ginestier C; Iovino F; Tarpin C; Diebel M; Esterni B; Houvenaeghel G; Extra JM; Bertucci F; Jacquemier J; Xerri L; Dontu G; Stassi G; Xiao Y; Barsky SH; Birnbaum D; Viens P; Wicha MS
Clin Cancer Res; 2010 Jan; 16(1):45-55. PubMed ID: 20028757
[TBL] [Abstract][Full Text] [Related]
38. Kallikrein expression as a prognostic factor in ovarian cancer: a systematic review and meta-analysis.
Wu Y; Lu M; Zhou Q
J BUON; 2015; 20(3):855-61. PubMed ID: 26214640
[TBL] [Abstract][Full Text] [Related]
39. The Prognostic Value of Cancer Stem Cell Markers in Cervical Cancer: A Systematic Review and Meta-Analysis.
Fahmi MN; Hertapanndika IN; Kusuma F
Asian Pac J Cancer Prev; 2021 Dec; 22(12):4057-4065. PubMed ID: 34967589
[TBL] [Abstract][Full Text] [Related]
40. Aldehyde dehydrogenase: its role as a cancer stem cell marker comes down to the specific isoform.
Marcato P; Dean CA; Giacomantonio CA; Lee PW
Cell Cycle; 2011 May; 10(9):1378-84. PubMed ID: 21552008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]